Stock Fundamentals

IBRX.US Logo

IBRX.US - Current Price

$2.08

Company Information

▼
Company Name
Immunitybio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45256X1037
CIK: 0001326110
CUSIP: 45256X103
Currency: USD
Full Time Employees: 673
Phone: 844 696 5235
Website: https://immunitybio.com
Fiscal Year End: December
IPO Date: Jul 28, 2015
Description:

ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.

Address:

3530 John Hopkins Court, San Diego, CA, United States, 92121

Directors & Officers

▼
Name Title Year Born
Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.Sc. Executive Chairman of the Board and Global Chief Scientific & Medical Officer 1953
Mr. Richard Gerald Adcock President, CEO & Director 1969
Mr. David C. Sachs Chief Financial Officer 1978
Dr. Barry J. Simon M.D. Chief Corporate Affairs Officer & Director 1965
Ms. Regan J. Lauer Chief Accounting Officer 1970
Dr. Enrique Diloné Ph.D., RAC Chief Technology Officer 1967
Ms. Sarah Singleton Chief Communications Officer & Head of Patient Advocacy NA
Ms. Emily Arison Senior Vice President of Human Resources NA
Dr. Leonard S. Sender M.D. Chief Medical Officer of Liquid Tumors & Cell Therapy NA
Dr. Sandeep K. Reddy M.D. Chief Medical Officer NA

Shares Statistics

▼
Shares Outstanding: 984.97M
Shares Float: 336.38M
% Insiders: 6,640.80%
% Institutions: 1,481.30%
Short % Float: 22.29%

Valuation Metrics

▼
Enterprise Value: $2.28B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $2.05B
EBITDA: $-244.95M
Book Value: $-0.53
Earnings/Share: $-0.41
Profit Margin: 0.00%
Operating Margin: -173.51%
ROA (TTM): -36.89%
ROE (TTM): 0.00%
Revenue (TTM): $82.56M
Revenue/Share (TTM): $0.10
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 425.10%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.11 N/A 10,000.00%
Sep 30, 2025 -0.07 -0.11 N/A 3,464.05%
Jun 30, 2025 -0.10 -0.11 N/A 909.09%
Mar 31, 2025 -0.15 -0.16 N/A 625.00%
Dec 31, 2024 -0.08 -0.13 N/A 3,846.15%
Sep 30, 2024 -0.12 -0.18 N/A 3,155.56%
Jun 30, 2024 -0.20 -0.17 N/A -1,764.71%
Mar 31, 2024 -0.20 -0.16 N/A -2,500.00%
Dec 31, 2023 -0.35 -0.18 N/A -9,444.44%
Sep 30, 2023 -0.19 -0.25 N/A 2,400.00%
Jun 30, 2023 -0.32 -0.23 N/A -3,913.04%
Mar 31, 2023 -0.27 -0.27 N/A 0.00%
Dec 31, 2022 -0.27 -0.22 N/A -2,272.73%
Sep 30, 2022 -0.28 -0.23 N/A -2,173.91%
Jun 30, 2022 -0.24 -0.24 N/A 0.00%
Mar 31, 2022 -0.26 -0.22 N/A -1,818.18%
Dec 31, 2021 -0.23 -0.21 N/A -952.38%
Sep 30, 2021 -0.22 -0.20 N/A -1,000.00%
Jun 30, 2021 -0.23 -0.12 N/A -9,166.67%
Mar 31, 2021 -0.21 -0.41 N/A 4,878.05%
Dec 31, 2020 -0.30 -0.18 N/A -6,666.67%
Sep 30, 2020 -0.20 -0.18 N/A -1,111.11%
Jun 30, 2020 -0.20 -0.19 N/A -526.32%
Mar 31, 2020 -0.19 -0.17 N/A -1,176.47%
Dec 31, 2019 -0.16 -0.20 N/A 2,000.00%
Sep 30, 2019 -0.16 -0.18 N/A 1,111.11%
Jun 30, 2019 -0.17 -0.24 N/A 2,916.67%
Mar 31, 2019 -0.22 -0.23 N/A 434.78%
Dec 31, 2018 -0.22 -0.31 N/A 2,903.23%
Sep 30, 2018 -0.30 -0.37 N/A 1,891.89%
Jun 30, 2018 -0.35 -0.38 N/A 789.47%
Mar 31, 2018 -0.35 -0.34 N/A -294.12%
Dec 31, 2017 -0.31 -0.33 N/A 606.06%
Sep 30, 2017 -0.30 -0.32 N/A 625.00%
Jun 30, 2017 -0.29 -0.31 N/A 645.16%
Mar 31, 2017 -0.30 -0.36 N/A 1,666.67%
Dec 31, 2016 -0.29 -0.43 N/A 3,255.81%
Sep 30, 2016 -0.39 -0.45 N/A 1,333.33%
Jun 30, 2016 -0.41 -0.58 N/A 2,931.03%
Mar 31, 2016 -0.38 -0.37 N/A -270.27%
Dec 31, 2015 -0.97 -0.23 N/A -32,173.91%
Sep 30, 2015 -0.55 -0.10 N/A -45,000.00%
Jun 30, 2015 -1.29 -0.13 N/A -89,230.77%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $143.43M $N/A $382.93M $871.06M $-489.10M
2023-12-31 $265.45M $N/A $504.45M $1.09B $-586.99M
2022-12-31 $104.64M $N/A $362.36M $812.18M $-447.33M
2021-12-31 $181.10M $N/A $468.91M $712.82M $-242.17M
2020-12-31 $34.92M $N/A $221.38M $339.87M $-119.81M
2019-12-31 $15.51M $N/A $143.12M $22.44M $120.68M
2018-12-31 $16.82M $N/A $181.95M $35.94M $146.01M
2017-12-31 $23.87M $N/A $250.44M $31.60M $218.84M
2016-12-31 $8.08M $N/A $317.50M $24.08M $293.42M
2015-12-31 $175.91M $N/A $366.85M $10.85M $356.00M
2014-12-31 $59.10M $N/A $60.83M $2.41M $58.42M
2013-12-31 $350.00K $N/A $2.10M $5.00M $-2.90M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 05, 2023 N/A N/A N/A N/A N/A N/A
Jun 02, 2023 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist